%0 Journal Article %A TORU AOYAMA %A KEISUKE KAZAMA %A YOSUKE ATSUMI %A HIROSHI TAMAGAWA %A AYAKA TAMAGAWA %A KEISUKE KOMORI %A DAISUKE MACHIDA %A YUKIO MAEZAWA %A KAZUKI KANO %A KENTARO HARA %A MASAAKI MURAKAWA %A MASAKATSU NUMATA %A TAKASHI OSHIMA %A NORIO YUKAWA %A MUNETAKA MASUDA %A YASUSHI RINO %T Clinical Influence of Anastomotic Leakage on Esophageal Cancer Survival and Recurrence %D 2020 %R 10.21873/anticanres.13972 %J Anticancer Research %P 443-449 %V 40 %N 1 %X Background: We investigated the clinical influence of anastomotic leak (AL) on esophageal cancer survival and recurrence after curative surgery. Patients and Methods: This study included 122 patients who underwent curative surgery for esophageal cancer between 2008 and 2018. The patients were classified into those with AL and those without. The risk factors for overall (OS) and recurrence-free (RFS) survival were identified. Results: AL was found in 44 out of the 122 patients (36.1%). The respective OS rates at 3 and 5 years after surgery were 43.9% and 40.2% in the AL group and 63.9% and 53.2% in the non-AL group, which were significantly different (p=0.0049). In contrast, the respective RFS rates at 3 and 5 years after surgery were 44.8% and 29.8%, and 44.9% and 42.4%, which were not significantly different (p=0.2306). A multivariate analysis showed that AL was a significant independent risk factor for both poorer OS and RFS in patients who underwent curative surgery for esophageal cancer. Conclusion: To improve survival of patients with esophageal cancer, the surgical procedure, perioperative care and surgical strategy must be carefully planned in order to prevent AL. %U https://ar.iiarjournals.org/content/anticanres/40/1/443.full.pdf